Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
Avgeris M, Tsilimantou A, Levis PK, Rampias T, Papadimitriou MA, Panoutsopoulou K, Stravodimos K, Scorilas A. Avgeris M, et al. Among authors: panoutsopoulou k. Carcinogenesis. 2019 Aug 22;40(8):965-974. doi: 10.1093/carcin/bgz045. Carcinogenesis. 2019. PMID: 30815670
miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study.
Panoutsopoulou K, Avgeris M, Mavridis K, Dreyer T, Dorn J, Obermayr E, Reinthaller A, Michaelidou K, Mahner S, Vergote I, Vanderstichele A, Braicu I, Sehouli J, Zeillinger R, Magdolen V, Scorilas A. Panoutsopoulou K, et al. Carcinogenesis. 2020 Jun 17;41(4):442-451. doi: 10.1093/carcin/bgz163. Carcinogenesis. 2020. PMID: 31586203
Circulating exosomal miRNAs: clinical significance in human cancers.
Avgeris M, Panoutsopoulou K, Papadimitriou MA, Scorilas A. Avgeris M, et al. Among authors: panoutsopoulou k. Expert Rev Mol Diagn. 2019 Nov;19(11):979-995. doi: 10.1080/14737159.2019.1673732. Epub 2019 Oct 20. Expert Rev Mol Diagn. 2019. PMID: 31594418 Review.
miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patients.
Panoutsopoulou K, Avgeris M, Magkou P, Mavridis K, Dreyer T, Dorn J, Obermayr E, Reinthaller A, Michaelidou K, Mahner S, Vergote I, Loverix L, Braicu I, Sehouli J, Zeillinger R, Magdolen V, Scorilas A. Panoutsopoulou K, et al. Int J Cancer. 2020 Dec 15;147(12):3560-3573. doi: 10.1002/ijc.33182. Epub 2020 Aug 1. Int J Cancer. 2020. PMID: 32621752
The interplay between miR-1245a and BRCA2 in colorectal cancer.
Scorilas A, Panoutsopoulou K, Tsiakanikas P. Scorilas A, et al. Among authors: panoutsopoulou k. Ann Transl Med. 2020 Sep;8(17):1043. doi: 10.21037/atm-2020-113. Ann Transl Med. 2020. PMID: 33145262 Free PMC article. No abstract available.
Epi-miRNAs: Modern mediators of methylation status in human cancers.
Papadimitriou MA, Panoutsopoulou K, Pilala KM, Scorilas A, Avgeris M. Papadimitriou MA, et al. Among authors: panoutsopoulou k. Wiley Interdiscip Rev RNA. 2023 Mar;14(2):e1735. doi: 10.1002/wrna.1735. Epub 2022 May 17. Wiley Interdiscip Rev RNA. 2023. PMID: 35580998 Review.
Epigenetic regulation of MIR145 core promoter controls miR-143/145 cluster in bladder cancer progression and treatment outcome.
Pilala KM, Papadimitriou MA, Panoutsopoulou K, Barbarigos P, Levis P, Kotronopoulos G, Stravodimos K, Scorilas A, Avgeris M. Pilala KM, et al. Among authors: panoutsopoulou k. Mol Ther Nucleic Acids. 2022 Oct 7;30:311-322. doi: 10.1016/j.omtn.2022.10.001. eCollection 2022 Dec 13. Mol Ther Nucleic Acids. 2022. PMID: 36320325 Free PMC article.
83 results